Skip to main content
SpringerLink
Log in

Minimising neurological damage takes priority in acute liver failure

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tissières P, Devictor D. Drug treatment of encephalopathy associated with fulminant liver failure. CNS Drugs 1999 (May); 11(5): 335–49

    Article  Google Scholar 

  2. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337: 473–9

    Article  PubMed  CAS  Google Scholar 

  3. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King’s criteria. J Hepatol 1997; 26: 62–68

    Article  PubMed  CAS  Google Scholar 

  4. Dodson SF, Dehara K, Iwatsuki S. Liver transplantation for fulminant hepatic failure. ASAIO J 1994; 40: 86–8

    PubMed  CAS  Google Scholar 

  5. Bismuth H, Samuel D, Castaing D, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis: the Paul Brousse experience. Ann Surg 1995; 222: 109–19

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minimising neurological damage takes priority in acute liver failure. Drugs Ther. Perspect 15, 4–7 (2000). https://doi.org/10.2165/00042310-200015070-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200015070-00002

Keywords

Search

Navigation